Pulmonary Artery Pressure as a Treatment Target to Improve the Prognosis of Idiopathic Pulmonary Arterial Hypertension　― Insight From a Cohort From Two Japanese Pulmonary Hypertension Centers ―

Background: The prognosis of pulmonary arterial hypertension (PAH) has been improving since the introduction of epoprostenol (EPO). The 3-year survival of naïve idiopathic PAH (IPAH) and hereditary PAH (HPAH) was 96% in a recent prospective Japanese registry. This increase in survival in Japan may h...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Circ Rep
Главные авторы: Ishiguro, Midori, Takeuchi, Kaori, Kikuchi, Hanako, Goda, Ayumi, Inami, Takumi, Tamura, Yuichi, Kataoka, Masaharu, Fukuda, Keiichi, Satoh, Toru
Формат: Artigo
Язык:Inglês
Опубликовано: The Japanese Circulation Society 2020
Предметы:
Original article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7921359/
https://ncbi.nlm.nih.gov/pubmed/33693237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-20-0006
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы